CIK: 0001594912
Total reported value
$29.2M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | TXG | 10x Genomics Inc-class A | Stock-Other | 93.76% | — | -9.99% | |
| 2 | NVAX | Novavax INC | Stock-Healthcare | 2.81% | — | — | |
| 3 | EPZMEUR | Epizyme INC | Stock-Other | 2.00% | — | — | |
| 4 | XLRN | Acceleron Pharma INC | Stock-Other | 1.43% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | NVAX | Novavax INC | +0.8% | — | Unchanged |
| 2 | TXG | 10x Genomics Inc-class A | +0.2% | -9.99% | Trim |
| 3 | XLRN | Acceleron Pharma INC | -0.1% | — | Unchanged |
| 4 | EPZMEUR | Epizyme INC | -0.9% | — | Unchanged |